170 related articles for article (PubMed ID: 2493099)
1. Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder.
Fukui I; Sekine H; Kihara K; Yamada T; Takeuchi S; Yokokawa M; Kawai T; Hosoda K; Ohwada F; Suzuki S
J Urol; 1989 Mar; 141(3):531-4. PubMed ID: 2493099
[TBL] [Abstract][Full Text] [Related]
2. Intravesical mitomycin C and doxorubicin sequential therapy for carcinoma in situ of the bladder: a longer followup result.
Sekine H; Fukui I; Yamada T; Ohwada F; Yokokawa M; Ohshima H
J Urol; 1994 Jan; 151(1):27-30. PubMed ID: 8254827
[TBL] [Abstract][Full Text] [Related]
3. Intravesical combination chemotherapy with mitomycin C and doxorubicin for superficial bladder cancer: a randomized trial of maintenance versus no maintenance following a complete response.
Fukui I; Kihara K; Sekine H; Tachibana Y; Kawai T; Ishiwata D; Oshima H
Cancer Chemother Pharmacol; 1992; 30 Suppl():S37-40. PubMed ID: 1394814
[TBL] [Abstract][Full Text] [Related]
4. [Sequential instillation therapy with mitomycin-C and adriamycin in superficial bladder tumor with special reference to fate of 43 patients achieving complete response].
Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S
Nihon Hinyokika Gakkai Zasshi; 1987 Sep; 78(9):1539-44. PubMed ID: 3127621
[No Abstract] [Full Text] [Related]
5. Histological grading of carcinoma in situ of the bladder: its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy.
Sekine H; Fukui I; Yamada T; Yamada T; Kojima S; Ohshima H
J Urol; 1996 Jan; 155(1):94-8; discussion 98-9. PubMed ID: 7490908
[TBL] [Abstract][Full Text] [Related]
6. Equivalent efficacy of mitomycin C plus doxorubicin instillation to bacillus Calmette-Guerin therapy for carcinoma in situ of the bladder.
Sekine H; Ohya K; Kojima SI; Igarashi K; Fukui I
Int J Urol; 2001 Sep; 8(9):483-6. PubMed ID: 11683967
[TBL] [Abstract][Full Text] [Related]
7. Conservative treatment of diffuse carcinoma in situ of the bladder with repeated courses of intravesical therapy.
Mukamel E; deKernion JB
Br J Urol; 1989 Aug; 64(2):143-6. PubMed ID: 2504435
[TBL] [Abstract][Full Text] [Related]
8. Topical mitomycin C therapy for carcinoma of the bladder.
Stricker PD; Grant AB; Hosken BM; Taylor JS
J Urol; 1987 Nov; 138(5):1164-6. PubMed ID: 3118056
[TBL] [Abstract][Full Text] [Related]
9. Intravesical mitomycin C for carcinoma in situ of the urinary bladder.
Hellsten S; Månsson W; Henrikson H; Idwall I; Lindholm K; Mikulowski P; Mårtensson S; Oldbring J
Scand J Urol Nephrol; 1990; 24(1):35-8. PubMed ID: 2108491
[TBL] [Abstract][Full Text] [Related]
10. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors.
Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S
Cancer Chemother Pharmacol; 1987; 20 Suppl():S52-5. PubMed ID: 3117399
[TBL] [Abstract][Full Text] [Related]
11. [Sequential intravesical chemotherapy with mitomycin C and adriamycin for superficial bladder tumor (preliminary report)].
Fukui I; Sekine H; Yamada T; Kihara K
Hinyokika Kiyo; 1985 Apr; 31(4):623-6. PubMed ID: 3929577
[TBL] [Abstract][Full Text] [Related]
12. 5-year experience with intravesical therapy of carcinoma in situ: an inquiry into the risks of "conservative" management.
Stanisic TH; Donovan JM; Lebouton J; Graham AR
J Urol; 1987 Nov; 138(5):1158-61. PubMed ID: 3118055
[TBL] [Abstract][Full Text] [Related]
13. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
Soloway MS
J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
[TBL] [Abstract][Full Text] [Related]
14. Intravesical chemotherapy for carcinoma in situ of the urinary bladder: 5 years later.
Jakse G
Eur Urol; 1984; 10(5):289-93. PubMed ID: 6440791
[TBL] [Abstract][Full Text] [Related]
15. Topical mitomycin C therapy for carcinoma in situ of the bladder: a followup.
Stricker PD; Grant AB; Hosken BM; Taylor JS
J Urol; 1990 Jan; 143(1):34-5; discussion 35-6. PubMed ID: 2104637
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients.
Huland H; Klöppel G; Feddersen I; Otto U; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F; Huland E
J Urol; 1990 Jul; 144(1):68-71; discussion 71-2. PubMed ID: 2113590
[TBL] [Abstract][Full Text] [Related]
17. Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors.
Huland H; Klöppel G; Otto U; Feddersen I; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F
Eur Urol; 1988; 14(3):202-6. PubMed ID: 3133216
[TBL] [Abstract][Full Text] [Related]
18. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer.
Isaka S; Okano T; Abe K; Shimazaki J
Cancer Chemother Pharmacol; 1992; 30 Suppl():S41-4. PubMed ID: 1394815
[TBL] [Abstract][Full Text] [Related]
19. Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes.
Gan C; Amery S; Chatterton K; Khan MS; Thomas K; O'Brien T
J Urol; 2016 Jun; 195(6):1697-703. PubMed ID: 26845426
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
Rintala E; Jauhiainen K; Alfthan O
Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
